Total Payments
$3,124
2024 Payments
$1,755
Companies
19
Transactions
135
Medicare Patients
1,047
Medicare Billing
$117,230
Payment Breakdown by Category
Food & Beverage$3,077 (98.5%)
Education$46.91 (1.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,077 | 134 | 98.5% |
| Education | $46.91 | 1 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $650.21 | 16 | $0 (2024) |
| ABBVIE INC. | $497.15 | 38 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $449.13 | 17 | $0 (2024) |
| Lundbeck LLC | $340.80 | 18 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $256.24 | 9 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $211.52 | 6 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $122.04 | 5 | $0 (2022) |
| ITI, Inc. | $118.49 | 5 | $0 (2023) |
| Axsome Therapeutics, Inc. | $112.44 | 1 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $69.40 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,755 | 69 | ABBVIE INC. ($298.96) |
| 2023 | $707.73 | 22 | Alkermes, Inc. ($280.94) |
| 2022 | $211.58 | 7 | Alkermes, Inc. ($103.57) |
| 2021 | $450.29 | 37 | AbbVie Inc. ($182.76) |
All Payment Transactions
135 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $5.62 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 12/11/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: CNS | ||||||
| 11/14/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: PSYCHIATRY | ||||||
| 11/13/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: CNS | ||||||
| 11/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.07 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: ANTI-ANXIETY | ||||||
| 11/03/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 10/30/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: PSYCHIATRY | ||||||
| 10/29/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $8.17 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 10/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.78 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $121.51 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/21/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $24.86 | General |
| Category: NEUROSCIENCE | ||||||
| 10/15/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: PSYCHIATRY | ||||||
| 10/14/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: PSYCHIATRY | ||||||
| 10/10/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: CNS | ||||||
| 10/08/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $112.44 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/03/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $3.91 | General |
| Category: PSYCHIATRY | ||||||
| 09/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.82 | General |
| Category: NEUROSCIENCE | ||||||
| 09/25/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: PSYCHIATRY | ||||||
| 09/19/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $18.21 | General |
| Category: PSYCHIATRY | ||||||
| 09/16/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: CNS | ||||||
| 09/12/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: PSYCHIATRY | ||||||
| 09/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: NEUROSCIENCE | ||||||
| 09/04/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 64 | 192 | $16,712 | $6,105 |
| 2022 | 5 | 156 | 391 | $38,714 | $11,484 |
| 2021 | 5 | 378 | 939 | $101,477 | $47,782 |
| 2020 | 6 | 449 | 1,090 | $118,520 | $51,859 |
Total Patients
1,047
Total Services
2,612
Medicare Billing
$117,230
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 49 | 164 | $12,792 | $4,744 | 37.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 15 | 28 | $3,920 | $1,362 | 34.7% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 78 | 312 | $24,336 | $7,699 | 31.6% |
| 90791 | Psychiatric diagnostic evaluation | Facility | 2022 | 27 | 27 | $8,019 | $2,563 | 32.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 20 | 21 | $3,024 | $925.31 | 30.6% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 19 | 19 | $1,615 | $188.11 | 11.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 12 | 12 | $1,720 | $108.65 | 6.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 113 | 270 | $40,000 | $18,475 | 46.2% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 158 | 441 | $37,485 | $18,034 | 48.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 67 | 161 | $17,320 | $8,188 | 47.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 18 | 37 | $3,672 | $1,746 | 47.5% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 22 | 30 | $3,000 | $1,340 | 44.7% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 179 | 507 | $43,095 | $21,591 | 50.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 130 | 315 | $46,970 | $18,386 | 39.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 81 | 186 | $20,005 | $7,738 | 38.7% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 33 | 40 | $4,000 | $1,932 | 48.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 15 | 31 | $3,150 | $1,469 | 46.6% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 11 | 11 | $1,300 | $742.70 | 57.1% |
About Deborah Tyson, NP
Deborah Tyson, NP is a Psychiatric/Mental Health healthcare provider based in Florence, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/11/2019. The National Provider Identifier (NPI) number assigned to this provider is 1164980017.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Deborah Tyson, NP has received a total of $3,124 in payments from pharmaceutical and medical device companies, with $1,755 received in 2024. These payments were reported across 135 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($3,077).
As a Medicare-enrolled provider, Tyson has provided services to 1,047 Medicare beneficiaries, totaling 2,612 services with total Medicare billing of $117,230. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatric/Mental Health
- Other Specialties Nurse Practitioner
- Location Florence, AL
- Active Since 03/11/2019
- Last Updated 05/06/2025
- Taxonomy Code 363LP0808X
- Entity Type Individual
- NPI Number 1164980017
Products in Payments
- REXULTI (Drug) $584.74
- VRAYLAR (Drug) $509.23
- LYBALVI (Drug) $326.41
- ARISTADA (Drug) $323.80
- SPRAVATO (Drug) $185.91
- CAPLYTA (Drug) $166.71
- UZEDY (Drug) $151.82
- ABILIFY ASIMTUFII (Drug) $138.72
- HETLIOZ (Drug) $122.04
- Auvelity (Drug) $112.44
- INVEGA SUSTENNA (Drug) $70.33
- TRINTELLIX (Drug) $69.40
- INGREZZA (Drug) $64.59
- Austedo XR (Drug) $59.70
- IGALMI (Drug) $46.54
- ABILIFY MAINTENA (Drug) $46.06
- LOREEV XR (Drug) $43.63
- Azstarys (Drug) $27.90
- BRINTELLIX (Drug) $20.41
- SUNOSI (Drug) $18.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatric/Mental Health Doctors in Florence
Lorie Jansen, Aprn, APRN
Psychiatric/Mental Health — Payments: $2,840
Psychiatric/Mental Health $2,840
Norah Lunga, Pmhnp, PMHNP
Psychiatric/Mental Health — Payments: $2,363
Psychiatric/Mental Health $2,363
Mrs. Roxian Odom, Pmhnp-Bc, PMHNP-BC
Psychiatric/Mental Health — Payments: $1,426
Psychiatric/Mental Health $1,426
Mr. William Queen, Pmhnp-Bc, PMHNP-BC
Psychiatric/Mental Health — Payments: $1,370
Psychiatric/Mental Health $1,370
Rebecca Powell, Aprn, Msn, Pmhnp-Bc, APRN, MSN, PMHNP-BC
Psychiatric/Mental Health — Payments: $1,216
Psychiatric/Mental Health $1,216
Caitlin Hibbett, Crnp, CRNP
Psychiatric/Mental Health — Payments: $1,046
Psychiatric/Mental Health $1,046